Satish Arora

Medicine · Health Sciences

24h-index1.8kcitations96works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Transplantation: Methods and Outcomes(65), Mechanical Circulatory Support Devices(24), Renal Transplantation Outcomes and Treatments(21), Viral Infections and Immunology Research(19), Cardiac Structural Anomalies and Repair(16)

Publications95 total

1171-P: Characteristics of Youths with Type 2 Diabetes Prescribed Sodium–Glucose Cotransporter 2 Inhibitors Surrounding FDA Approval at an Academic Pediatric Medical Center
Diabetes·2025
The Effect of Everolimus Versus Calcineurin Inhibitors on Quality of Life 10–12 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (SCHEDULE Trial)
Clinical Transplantation·2024· 1 citedOpen Access
Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients
JACC Heart Failure·2024· 19 citedOpen Access
The Effect of Everolimus vs Calcineurin Inhibitors on Quality of Life 11 Years After Heart Transplantation: The Results of a Randomized Controlled Trial (Schedule Trial)
The Journal of Heart and Lung Transplantation·2024Open Access
Prognostic value of intravascular ultrasound early after heart transplantation
European Heart Journal·2023· 4 citedOpen Access
IMPACT OF MYOCARDIAL BRIDGING ON LONG TERM OUTCOMES AFTER HEART TRANSPLANTATION: AN INTRAVASCULAR ULTRASOUND OBSERVATION FROM AN INTERNATIONAL MULTICENTER HEART TRANSPLANT REGISTRY
Journal of the American College of Cardiology·2023
Multicenter Evaluation of Volumetric Intravascular Ultrasound Early After Heart Transplantation and Long-Term Prognosis
The Journal of Heart and Lung Transplantation·2022Open Access
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation
European Heart Journal·2021· 47 citedOpen Access
Patient perceptions of the re-usable Respimat<sup>®</sup> Soft Mist™ inhaler in current users and those switching to the device: A real-world, non-interventional COPD study
Chronic Respiratory Disease·2021· 4 citedOpen Access
Late Breaking Abstract - Switching from a disposable to a re-usable inhaler: patient satisfaction and preference
2020
Invasive Haemodynamics in <i>De Novo</i> Everolimus vs. Calcineurin Inhibitor Heart Transplant Recipients
ESC Heart Failure·2020· 1 citedOpen Access
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients—a SCHEDULE trial substudy
Transplant International·2020· 6 citedOpen Access
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection
The Journal of Heart and Lung Transplantation·2019· 21 citedOpen Access
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study
Transplantation·2019· 47 cited
Mild Acute Cellular Rejection is Not Associated with Development of Cardiac Allograft Vasculopathy Assessed by Intravascular Ultrasound and Coronary Angiography in Heart Transplant Recipients - A Substudy of the SCHEDULE Trial
The Journal of Heart and Lung Transplantation·2019
Effect of High-Intensity Interval Training on Progression of Coronary Artery Vasculopathy in De Novo Heart Transplant Recipients
The Journal of Heart and Lung Transplantation·2019
EVOLVD: Cholesterol Lowering with EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-Novo Heart Transplant Recipients: Rationale and Design of a Randomized, Controlled Trial
The Journal of Heart and Lung Transplantation·2019· 3 cited
Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation
Cardiovascular Diabetology·2019· 10 citedOpen Access
Circulating delta-like Notch ligand 1 is correlated with cardiac allograft vasculopathy and suppressed in heart transplant recipients on everolimus-based immunosuppression
American Journal of Transplantation·2018· 11 citedOpen Access
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients
Circulation Heart Failure·2018· 52 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Lars Gullestad(41), L Gullestad(32), S Simonsen(28), Hans Eiskjær(17), Finn Gustafsson(15), D. Solbu(14), Göran Dellgren(14), Kristjan Karason(12), Svein Simonsen(12), Göran Rådegran(11), Thor Ueland(11), Odd Geiran(11), Pål Aukrust(10), Bert Andersson(7), Arnt E. Fiane(7), Kjell Jansson(6), I. Grov(6), V. Sigurdardottir(5), Lars Aaberge(5), Ole Geir Solberg(5)